Single-use Bioreactors Market – Product Launches is the Key Growth Strategy Adopted by Market Players
According to research report the single-use bioreactors market is expected to reach USD 2,685.1 Million by 2022 from USD 997.6 Million in 2017, at a CAGR 21.9%. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and, Thermo Fisher Scientific (US). Increasing adoption of SUBs among small companies and startups and reduced automation complexity are the major factors driving the adoption of single-use bioreactors.
Most companies focus on launching new products to compete in the market. The players also focus on increasing their presence in high-growth markets through agreements, expansions, and acquisitions. Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US) focus on product launches and enhancements to strengthen their position in the market.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=49113750
Sartorius Stedim Biotech’s leading position in the single-use bioreactors market can be attributed to its strong product portfolio and wide geographic presence (spanning the Americas, EMEA, and APAC). The company focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and acquisitions. In 2016, the company launched ambr 250, a benchtop mini bioreactor system for parallel fermentation and cell culture. In 2014, the company acquired a majority stake in AllPure Technologies (US). Through this acquisition, the company strengthened its market share in the single-use bioprocessing products market.
Merck Millipore is among the leading players in the single-use bioreactors market. The company offers a strong product portfolio of single-use bioreactor systems and single-use connectors. In order to strengthen its presence and generate a large market share, the company is adopting strategies such as product launches and acquisitions. In 2016, Merck Millipore launched the Mobius 1000L single-use bioreactor. In 2015, Merck acquired Sigma-Aldrich Corporation (US), a life sciences and high-technology company. This acquisition helped Merck to enhance its product portfolio and strengthen its customer base.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750
Some other leading players in the global single-use bioreactors market are Parkin Hannifin (US), Applikon Biotechnology (Netherlands), Eppendorf (Germany), Cesco Bioengineering (Taiwan), and Cellexus (UK). These companies focus significantly on investing in R&D activities to add innovative technologies and products to their portfolio. With a strong portfolio of single-use bioreactor products and ceaseless efforts to develop innovative products, these companies are likely to maintain their strong position in the market in the coming years.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441